Acquired Resistance to Osimertinib Plus Savolitinib Is Mediated by MET-D1228 and MET-Y1230 Mutations in EGFR-Mutated MET-Amplified Lung Cancer.

ABSTRACT:

SUBMITTER: Piper-Vallillo AJ 

PROVIDER: S-EPMC7305494 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature